Tajikistan Triples the Production of Medicines
Read also
DUSHANBE, 02.10.2023 (NIAT Khovar) – The volume of exports of biologically active herbal supplements from Tajikistan this year increased by 63.25 million somoni compared to last year. This was stated on September 29 during the Dushanbe International Investment Forum — 2023 in the section “Investment opportunities in the healthcare sector, prospects for the development of the pharmaceutical sector and private medicine in Tajikistan.”
The volume of production of medicines and medical products produced in Tajikistan in 2022 compared to the same period the year before increased by 3 times.
The State Program for the Development of the Pharmaceutical Industry in Tajikistan for 2021-2025 is being successfully implemented to develop the pharmaceutical industry in the country.
As part of the program, 58 domestic enterprises began producing 560 types of medicines and medical products.
These enterprises provide new jobs for more than 450 specialists and workers, and up to 4,000 workers are involved in seasonal work.
Tajikistan Discusses Export Development Program for 2026–2030
Moody’s Upgrades Tajikistan to B2, Cites Strong Economy and Fiscal Stability
Tajikistan, Islamic Development Bank Pledge to Expand Cooperation
ADB to Mobilize $1.1 Billion for Tajikistan Under 2026–2030 Strategy
Tajikistan, Turkmenistan Hold 14th Intergovernmental Commission Meeting
Tajikistan, ADB Launch 2026–2030 Strategy as $914.7 Million in Projects Underway
Tajikistan, World Bank Discuss Expanding Financial Cooperation
Tajik Delegation Holds Investment Talks With International Financial Institutions in London
Tajikistan, United Nations Discuss 2027-2030 Sustainable Development Agenda
Tajik and Kazakh Railway Leaders Agree on Development of Transport Corridors
Financing Issues Related to the Continued Construction of the Rogun HPP Discussed in Dushanbe
Implementation of Investment Projects and Attraction of Asian Development Bank Funds to Tajikistan’s Economy Discussed in Dushanbe
